Document Detail


Benefits and risks of calcium resonium therapy in hyperkalaemic preterm infants.
MedLine Citation:
PMID:  12650312     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSION: The risks and benefits of exchange resins in prematurely born infants should be assessed in an appropriately sized randomized trial.
Authors:
T Grammatikopoulos; A Greenough; C Pallidis; M Davenport
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Acta paediatrica (Oslo, Norway : 1992)     Volume:  92     ISSN:  0803-5253     ISO Abbreviation:  Acta Paediatr.     Publication Date:  2003  
Date Detail:
Created Date:  2003-03-24     Completed Date:  2003-06-19     Revised Date:  2014-07-28    
Medline Journal Info:
Nlm Unique ID:  9205968     Medline TA:  Acta Paediatr     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  118-20     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Hyperkalemia / drug therapy*
Infant, Newborn
Infant, Premature
Infant, Very Low Birth Weight
Intestinal Perforation / etiology*
Male
Polystyrenes / adverse effects,  therapeutic use*
Risk Factors
Chemical
Reg. No./Substance:
0/Polystyrenes; 28210-41-5/polystyrene sulfonic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Higher drive for thinness in adolescent males with insulin-dependent diabetes mellitus compared with...
Next Document:  Conversion reaction presenting as a polyradiculonevritis.